Ascendis Pharma A (ASND) Other Working Capital Changes (2019 - 2026)

Ascendis Pharma A has reported Other Working Capital Changes for 8 years, with the latest figure at $7.6 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 2697.05% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.5 million (up 60.73% YoY) and the FY2025 annual result came in at $90.3 million, up 36.38% from the prior year.
• Other Working Capital Changes retreated to $7.6 million in Q1 2026 per ASND's latest filing, from $34.1 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $7.1 million in Q3 2023 and troughed at -$10.9 million in Q1 2023.
• A 5-year average of -$1.1 million and a median of -$2.8 million in 2023 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 3826.88% in 2024, then plunged 691.06% in 2025.
• Over 5 years, Other Working Capital Changes stood at $1.2 million in 2022, then jumped by 1059.34% to $14.1 million in 2023, then tumbled by 160.59% to -$8.5 million in 2024, then soared by 499.57% to $34.1 million in 2025, then plunged by 77.57% to $7.6 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $7.6 million, $34.1 million, and -$20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.